Cargando…
A New Pharmacophore Model for the Design of Sigma-1 Ligands Validated on a Large Experimental Dataset
The recent publication of the σ1R crystal structure is an important cornerstone for the derivation of more accurate activity prediction models. We report here a comparative study involving a set of more than 25,000 structures from our internal database that had been screened for σ1R affinity. Using...
Autores principales: | Pascual, Rosalia, Almansa, Carmen, Plata-Salamán, Carlos, Vela, José Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555132/ https://www.ncbi.nlm.nih.gov/pubmed/31214020 http://dx.doi.org/10.3389/fphar.2019.00519 |
Ejemplares similares
-
Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?
por: Vela, José Miguel
Publicado: (2020) -
Co-crystals as a new approach to multimodal analgesia and the treatment of pain
por: Almansa, Carmen, et al.
Publicado: (2019) -
Inhibitory Effects of Sigma-2 Receptor Agonists on T Lymphocyte Activation
por: Iñiguez, Miguel A., et al.
Publicado: (2013) -
Pharmacophore and docking-based sequential virtual screening for the identification of novel Sigma 1 receptor ligands
por: Alamri, Mubarak A, et al.
Publicado: (2019) -
Hazards of Using Masking Protocols When Performing Ligand Binding Assays: Lessons From the Sigma-1 and Sigma-2 Receptors
por: Abbas, Haider, et al.
Publicado: (2020)